ArticleThe oncologist2025

Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).

Erick F Saldanha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.